Body weight (BW)

Body weight is a physiological measurement of an individual's total mass and serves as a fundamental clinical endpoint rather than a single molecular target or receptor. It represents the phenotypic outcome of a highly complex and integrated network involving genetics, behavioral factors, and neuroendocrine systems that regulate energy intake and expenditure [11, 14]. In therapeutic contexts, body weight is the primary metric used to evaluate the efficacy of treatments for obesity, metabolic syndrome, and wasting conditions like cachexia [18, 19]. Drugs marketed to manage body weight, such as semaglutide and tirzepatide, do so by targeting specific molecular pathways—primarily the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors—to induce satiety and slow gastric emptying [12, 15]. Biotech analysts monitor body weight reduction as a gold-standard indicator of clinical success in metabolic drug development pipelines, though recent emphasis has shifted toward evaluating body composition (ratio of fat to lean mass) and long-term metabolic health alongside total mass [14]. Understanding the mechanisms that drive body weight fluctuations is essential for developing next-generation poly-agonists and personalized metabolic therapies [11, 13].

Other names

Total body massBody massBody mass index (BMI)AdiposityWeight status

Pharmacological interventions affect body weight by modulating energy balance through various specific molecular targets. These include the suppression of appetite via GLP-1, GIP, or melanocortin receptors in the central nervous system, the inhibition of dietary fat absorption in the gastrointestinal tract, or the increase of energy expenditure through metabolic pathways.